Developer docs
API playgroundTry for free, no card

Search company profiles

Labtician Ophthalmics

Full company profile

uuid000cfwg

Namestring
Labtician Ophthalmics
Legal namestring
Labtician Ophthalmics, Inc.
Websiteurl
labtician.com
Company typeenum
Private
Founded yearint
1959
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOakville, Canada
HQ citystring
Oakville
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic medical devices, eye care distribution, surgical instruments, dry eye therapy, retina care products
Industry4 codes
1Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
CodeHLAHAJAEPrimaryYes
2Ocular Drug Delivery Devices (Eye Droppers/Inserts)
CodeHLAHAIALPrimaryNo
3Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants)
CodeHLAHAJALPrimaryNo
4Ophthalmology Specialty Pharmaceuticals
CodeHLAIACAKPrimaryNo
NAICS code4 codes
  • Ophthalmic Goods Merchant Wholesalers423460
  • Ophthalmic Goods Manufacturing339115
  • Biological Product (except Diagnostic) Manufacturing325414
  • Optical Goods Retailers456130
SIC code2 codes
  • Ophthalmic Goods3851
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Distribution and commercialization of ophthalmic medical devices and therapeutic products
TypeHardware Sales
Description

Labtician acts as the exclusive or preferred Canadian commercialization partner for a portfolio of international eye care brands. The company generates revenue by importing, distributing, and selling surgical instruments, therapeutic eye products, and medical devices to eye care professionals (B2B) and patients (B2C/B2B2C) across Canada, earning margins on product sales. Additional revenue comes from online direct-to-consumer sales through its e-commerce portal (labticianorderonline.ca).

labtician.com
2Endoret PRGF treatment services
TypeHardware Sales
Description

Labtician facilitates the PRGF (Plasma Rich in Growth Factors) treatment process through a network of Coverdale clinic locations across Canada. Patients pay approximately $800 CAD per treatment session (3-month supply of up to 32 droppers). Labtician coordinates the supply of the PRGF kit/components and connects patients to authorized treatment centres.

labtician.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Endoret PRGF treatment — approximately $800 CAD per treatment session
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Each treatment session yields up to 32 droppers (3-month supply), stored frozen at -20°C. If 32 droppers cannot be generated from the blood draw, the cost of $800.00 remains the same. Treatment can be extended in 3-month cycles under clinical supervision.

labtician.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1LabTRIACTIV
Description

Multi-layered eye drop product for dry eye treatment targeting all three components of the tear film

labtician.com
+7 more records
Core offering1 text field

Labtician Ophthalmics is a Canadian commercialization partner for international eye care brands and manufacturer/distributor of its own-branded ophthalmic medical devices and therapeutic products. The company imports, distributes, and sells a comprehensive portfolio covering surgical instruments (LabEdge blades, knives, cannulas, trephines), vitreoretinal products (Labtician LSO silicone oil, retinal implants, Fluoron silicone oils), glaucoma devices (KDB Glide, Ahmed valves), dry eye therapies (LabTRIACTIV drops, LabHEAT mask, PRGF autologous eye drops, LabEssentials kit), and oculoplasty products to eye care professionals (ophthalmologists and optometrists) and patients across Canada, with international distribution reach spanning 60+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 493+ ophthalmic products commercialized across Canada
+2 more records
Product overview1 text field

Labtician Ophthalmics is a Canadian commercialization partner for ophthalmic and optometric solutions, offering a comprehensive portfolio of surgical and therapeutic products across multiple eye conditions. The company distributes its own branded products (LabTRIACTIV, PRGF, LabEssentials Dry Eye Kit, LabHEAT, surgical instruments) as well as products from partner manufacturers (New World Medical, MST, Geuder, Fluoron, Bruder Healthcare, PRN, Ocular Instruments, Zocular, BioTissue, Ophtec). Products cover therapeutic areas including dry eye, cataract, cornea, glaucoma, retina, ENT, and oculoplasty. The company operates primarily as a distributor and commercialization partner rather than a technology developer, bringing clinically proven products to the Canadian market through regulatory expertise and education-focused partnerships.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeTechnology or Integration
Description

New World Medical is a key partner providing surgical devices such as the KDB Glide (Kahook Dual Blade), Ahmed ClearPath, and Ahmed Glaucoma Valve. Labtician distributes these products in Canada, supporting glaucoma management and surgical solutions for eye care professionals.

Strategic tierCoreTypeTechnology or Integration
Description

MST provides precision surgical instruments and catalogues featured in Labtician's product portfolio. Labtician distributes MST's surgical instrument catalogue across Canada.

Strategic tierCoreTypeTechnology or Integration
Description

Bruder Healthcare supplies therapeutic products for dry eye management including the Bruder Mask (microwave-activated heat compress) and Bruder Cold Therapy Eye Compress. These are featured in Labtician's LabEssentials Dry Eye Kit and are available through the clinic locator and e-commerce portal.

Strategic tierCoreTypeTechnology or Integration
Description

PRN supplies pharmaceutical-grade omega-3 supplements (PRN Omega Liquid and PRN Omega Softgels) for dry eye management. These supplements are incorporated into Labtician's LabEssentials Dry Eye Kit and are available through eye care professionals and the e-commerce portal.

Strategic tierCoreTypeTechnology or Integration
Description

Geuder GmbH is a German manufacturer of precision ophthalmic surgical instruments. Labtician distributes Geuder's DMEK Cartridge and general surgical instruments in Canada, supporting cornea and cataract surgical procedures.

Strategic tierCoreTypeTechnology or Integration
Description

Fluoron GmbH supplies advanced vitreoretinal substitutes including Siluron Silicone Oil, Densiron Xtra Heavy Silicone Oil, F4H5 Washout, F Decalin/F Octane PFCL Syringes, F6H8 Vitreous Substitute, and EasyGas SF6 gas. These products support complex retinal detachment repair and vitreoretinal surgery.

Strategic tierCoreTypeTechnology or Integration
Description

BioTissue provides amniotic membrane products including AmnioGuard and AmnioGraft for corneal and ocular surface regeneration. Labtician distributes these tissue products in Canada, supporting advanced wound healing and tissue repair applications.

8Zocular
Strategic tierCoreTypeTechnology or Integration
Description

Zocular supplies ophthalmic eyelid and lash hygiene products including ZocuFoam, ZocuShield, ZocuWipe, and the ZOCUKIT (ZEST). These are distributed by Labtician for blepharitis and lid margin disease management.

labtician.com
Strategic tierCoreTypeTechnology or Integration
Description

Ophtec is featured as a current partner in Labtician's partner portfolio. Specific products or collaboration details are not detailed in the available source content.

Strategic tierCoreTypeTechnology or Integration
Description

Ocular Instruments Inc. supplies ophthalmic instruments and accessories distributed by Labtician in Canada. Their full product catalogue is available through Labtician's catalogues page.

Strategic tierCoreTypeTechnology or Integration
Description

BTI (Biotechnology Institute) is the developer of Endoret PRGF (Plasma Rich in Growth Factors) technology. Labtician serves as the exclusive Canadian commercial partner for Endoret PRGF, distributing the autologous eye drop therapy through a network of Coverdale clinic locations across Canada (BC, AB, MB, ON, QC, NS).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Eye care professionals across Canada are key channel partners who prescribe and dispense Labtician products to patients. The company provides Territory Manager support, clinical education, and product resources to enable these professionals to adopt and offer Labtician-distributed solutions in their practices.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Labtician partners with distributors in over 60 countries spanning North America, Europe, Latin America, Middle East & Africa, and Asia & Pacific to provide global market access for partner brands and reach patients internationally beyond Canada.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based ophthalmic medical technology company focused on interventional glaucoma devices, MIGS products and procedural pharmaceuticals — directly comparable to the surgical device distribution and glaucoma franchises (e.g., NWM KDB Glide, Ahmed devices) that Labtician commercializes in Canada.

TypeDirect peer
Description

US-based ophthalmic device company developing interventional surgical technologies for glaucoma and dry eye disease — directly comparable to Labtician's mix of surgical devices, dry eye therapeutics (TEAR product), and Canadian commercialization role.

TypeDirect peer
Description

Global ophthalmic surgical device company focused on cataract, vitreoretinal, and refractive surgery instruments and IOLs — directly comparable to Labtician's surgical instrument and retina (silicone oil, PFCL, vitrectomy adjuncts) product franchises.

TypeBroad incumbent
Description

Global leader in ophthalmic surgical devices, pharmaceuticals, and consumer vision care across cataract, retina, glaucoma, and dry eye — overlapping broadly with Labtician's distribution, surgical instrument, and dry eye product portfolios, but at vastly larger direct scale.

TypeDirect peer
Description

Ophthalmic surgical device company specializing in intraocular lenses and refractive surgery products — peer to Labtician's cataract, cornea, and surgical instrument categories around which it builds a commercial product portfolio.

TypeDirect peer
Description

Ophthalmic laser-based medical device company selling retina and glaucoma treatment systems — comparable specialty-ophthalmic device manufacturer competing for similar retina and surgical ophthalmology customers.

TypeEmerging player
Description

US-based ophthalmic pharmaceutical company with specialty products in dry eye and ocular surface disease (Aganocide / i-Lid / NovaWipes) — emerging player in the same therapeutic categories where Labtician distributes partner brands (Zocular, Bruder, PRN, LabTRIACTIV).

TypeBroad incumbent
Description

Japanese-headquartered ophthalmic diagnostic imaging, refraction, and surgical equipment vendor — broader incumbent competitor to Labtician's ophthalmic surgical instrument and device distribution categories.

TypeBroad incumbent
Description

German-headquartered global leader in ophthalmic diagnostic and surgical equipment and consumables, operating across cataract, glaucoma, retina and refractive segments in parallel with Labtician's surgical and therapeutic portfolio.

TypeBroad incumbent
Description

Major global ophthalmic company with surgical, pharmaceutical, and consumer vision care businesses that competes broadly with Labtician's product span in dry eye therapeutics, surgical consumables, and lens/intravitreal injection categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labtician Ophthalmics

Ophthalmic Medical Deviceslabtician.com

Labtician Ophthalmics firmographics

Firmographics
Name
Labtician Ophthalmics
Legal name
Labtician Ophthalmics, Inc.
Website
https://labtician.com
Company type
Private
Founded year
1959
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Labtician Ophthalmics industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Ophthalmic Goods Merchant Wholesalers (423460), Ophthalmic Goods Manufacturing (339115), Biological Product (except Diagnostic) Manufacturing (325414), Optical Goods Retailers (456130)
SIC
Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)
akta.pro secondary industries
Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL), Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL), Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

Keywords

  • Ophthalmic medical devices
  • Eye care distribution
  • Surgical instruments
  • Dry eye therapy
  • Retina care products

Where Labtician Ophthalmics is headquartered

Location

Headquarters

HQ city
Oakville
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Labtician Ophthalmics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Distribution and commercialization of ophthalmic medical devices and therapeutic products: Labtician acts as the exclusive or preferred Canadian commercialization partner for a portfolio of international eye care brands. The company generates revenue by importing, distributing, and selling surgical instruments, therapeutic eye products, and medical devices to eye care professionals (B2B) and patients (B2C/B2B2C) across Canada, earning margins on product sales. Additional revenue comes from online direct-to-consumer sales through its e-commerce portal (labticianorderonline.ca).
  2. Endoret PRGF treatment services: Labtician facilitates the PRGF (Plasma Rich in Growth Factors) treatment process through a network of Coverdale clinic locations across Canada. Patients pay approximately $800 CAD per treatment session (3-month supply of up to 32 droppers). Labtician coordinates the supply of the PRGF kit/components and connects patients to authorized treatment centres.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractEndoret PRGF treatment — approximately $800 CAD per treatment session

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Labtician Ophthalmics product offering

Product offering

Core offering

Labtician Ophthalmics is a Canadian commercialization partner for international eye care brands and manufacturer/distributor of its own-branded ophthalmic medical devices and therapeutic products. The company imports, distributes, and sells a comprehensive portfolio covering surgical instruments (LabEdge blades, knives, cannulas, trephines), vitreoretinal products (Labtician LSO silicone oil, retinal implants, Fluoron silicone oils), glaucoma devices (KDB Glide, Ahmed valves), dry eye therapies (LabTRIACTIV drops, LabHEAT mask, PRGF autologous eye drops, LabEssentials kit), and oculoplasty products to eye care professionals (ophthalmologists and optometrists) and patients across Canada, with international distribution reach spanning 60+ countries.

Product overview

Labtician Ophthalmics is a Canadian commercialization partner for ophthalmic and optometric solutions, offering a comprehensive portfolio of surgical and therapeutic products across multiple eye conditions. The company distributes its own branded products (LabTRIACTIV, PRGF, LabEssentials Dry Eye Kit, LabHEAT, surgical instruments) as well as products from partner manufacturers (New World Medical, MST, Geuder, Fluoron, Bruder Healthcare, PRN, Ocular Instruments, Zocular, BioTissue, Ophtec). Products cover therapeutic areas including dry eye, cataract, cornea, glaucoma, retina, ENT, and oculoplasty. The company operates primarily as a distributor and commercialization partner rather than a technology developer, bringing clinically proven products to the Canadian market through regulatory expertise and education-focused partnerships.

Differentiator

Problem solved

Functional benefit

Brands

  • LabTRIACTIV: Multi-layered eye drop product for dry eye treatment targeting all three components of the tear film
  • LabHEAT
  • LabEssentials
  • LabRELEEV
  • LabEdge
  • LabCannula
  • LabTrephine
  • LabSpear

Quantifiable outcome

  • 493+ ophthalmic products commercialized across Canada
  • +2 more outcomes

Companies that use Labtician Ophthalmics

Customer profile

Named customers9 records

Segments2 records

Ideal customer profiles2 records

Labtician Ophthalmics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Labtician Ophthalmics partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core.

  • New World MedicalcoreTechnology or IntegrationNew World Medical is a key partner providing surgical devices such as the KDB Glide (Kahook Dual Blade), Ahmed ClearPath, and Ahmed Glaucoma Valve. Labtician distributes these products in Canada, supporting glaucoma management and surgical solutions for eye care professionals.
  • MST (MicroSurgical Technology)coreTechnology or IntegrationMST provides precision surgical instruments and catalogues featured in Labtician's product portfolio. Labtician distributes MST's surgical instrument catalogue across Canada.
  • Bruder HealthcarecoreTechnology or IntegrationBruder Healthcare supplies therapeutic products for dry eye management including the Bruder Mask (microwave-activated heat compress) and Bruder Cold Therapy Eye Compress. These are featured in Labtician's LabEssentials Dry Eye Kit and are available through the clinic locator and e-commerce portal.
  • PRN (Physician Recommended Nutriceuticals)coreTechnology or IntegrationPRN supplies pharmaceutical-grade omega-3 supplements (PRN Omega Liquid and PRN Omega Softgels) for dry eye management. These supplements are incorporated into Labtician's LabEssentials Dry Eye Kit and are available through eye care professionals and the e-commerce portal.
  • Geuder GmbHcoreTechnology or IntegrationGeuder GmbH is a German manufacturer of precision ophthalmic surgical instruments. Labtician distributes Geuder's DMEK Cartridge and general surgical instruments in Canada, supporting cornea and cataract surgical procedures.
  • Fluoron GmbHcoreTechnology or IntegrationFluoron GmbH supplies advanced vitreoretinal substitutes including Siluron Silicone Oil, Densiron Xtra Heavy Silicone Oil, F4H5 Washout, F Decalin/F Octane PFCL Syringes, F6H8 Vitreous Substitute, and EasyGas SF6 gas. These products support complex retinal detachment repair and vitreoretinal surgery.
  • BioTissue (Bio- Tissue Inc.)coreTechnology or IntegrationBioTissue provides amniotic membrane products including AmnioGuard and AmnioGraft for corneal and ocular surface regeneration. Labtician distributes these tissue products in Canada, supporting advanced wound healing and tissue repair applications.
  • ZocularcoreTechnology or IntegrationZocular supplies ophthalmic eyelid and lash hygiene products including ZocuFoam, ZocuShield, ZocuWipe, and the ZOCUKIT (ZEST). These are distributed by Labtician for blepharitis and lid margin disease management.
  • OphteccoreTechnology or IntegrationOphtec is featured as a current partner in Labtician's partner portfolio. Specific products or collaboration details are not detailed in the available source content.
  • Ocular Instruments Inc.coreTechnology or IntegrationOcular Instruments Inc. supplies ophthalmic instruments and accessories distributed by Labtician in Canada. Their full product catalogue is available through Labtician's catalogues page.
  • BTI (Biotechnology Institute / BTI Biotechnology Institute)coreTechnology or IntegrationBTI (Biotechnology Institute) is the developer of Endoret PRGF (Plasma Rich in Growth Factors) technology. Labtician serves as the exclusive Canadian commercial partner for Endoret PRGF, distributing the autologous eye drop therapy through a network of Coverdale clinic locations across Canada (BC, AB, MB, ON, QC, NS).
  • Eye Care Professionals (Ophthalmologists & Optometrists)coreChannel Partner/ Reseller/ DistributorEye care professionals across Canada are key channel partners who prescribe and dispense Labtician products to patients. The company provides Territory Manager support, clinical education, and product resources to enable these professionals to adopt and offer Labtician-distributed solutions in their practices.
  • International DistributorscoreChannel Partner/ Reseller/ DistributorLabtician partners with distributors in over 60 countries spanning North America, Europe, Latin America, Middle East & Africa, and Asia & Pacific to provide global market access for partner brands and reach patients internationally beyond Canada.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Labtician Ophthalmics competitors and assessment

Company assessment

Direct peers

  • Glaukos Corporation: US-based ophthalmic medical technology company focused on interventional glaucoma devices, MIGS products and procedural pharmaceuticals — directly comparable to the surgical device distribution and glaucoma franchises (e.g., NWM KDB Glide, Ahmed devices) that Labtician commercializes in Canada.
  • Sight Sciences: US-based ophthalmic device company developing interventional surgical technologies for glaucoma and dry eye disease — directly comparable to Labtician's mix of surgical devices, dry eye therapeutics (TEAR product), and Canadian commercialization role.
  • BVI (BVI Medical): Global ophthalmic surgical device company focused on cataract, vitreoretinal, and refractive surgery instruments and IOLs — directly comparable to Labtician's surgical instrument and retina (silicone oil, PFCL, vitrectomy adjuncts) product franchises.
  • STAAR Surgical: Ophthalmic surgical device company specializing in intraocular lenses and refractive surgery products — peer to Labtician's cataract, cornea, and surgical instrument categories around which it builds a commercial product portfolio.
  • Iridex Corporation: Ophthalmic laser-based medical device company selling retina and glaucoma treatment systems — comparable specialty-ophthalmic device manufacturer competing for similar retina and surgical ophthalmology customers.

Broad incumbents

  • Alcon: Global leader in ophthalmic surgical devices, pharmaceuticals, and consumer vision care across cataract, retina, glaucoma, and dry eye — overlapping broadly with Labtician's distribution, surgical instrument, and dry eye product portfolios, but at vastly larger direct scale.
  • Topcon Healthcare: Japanese-headquartered ophthalmic diagnostic imaging, refraction, and surgical equipment vendor — broader incumbent competitor to Labtician's ophthalmic surgical instrument and device distribution categories.
  • Carl Zeiss Meditec: German-headquartered global leader in ophthalmic diagnostic and surgical equipment and consumables, operating across cataract, glaucoma, retina and refractive segments in parallel with Labtician's surgical and therapeutic portfolio.
  • Bausch + Lomb: Major global ophthalmic company with surgical, pharmaceutical, and consumer vision care businesses that competes broadly with Labtician's product span in dry eye therapeutics, surgical consumables, and lens/intravitreal injection categories.

Emerging players

  • NovaBay Pharmaceuticals: US-based ophthalmic pharmaceutical company with specialty products in dry eye and ocular surface disease (Aganocide / i-Lid / NovaWipes) — emerging player in the same therapeutic categories where Labtician distributes partner brands (Zocular, Bruder, PRN, LabTRIACTIV).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Labtician Ophthalmics social profiles

Digital presence

Labtician Ophthalmics compliance and trust

Trust signal

Compliance1 record

Labtician Ophthalmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labtician Ophthalmics leadership team

Management profile

Number of profiles

Profiles4 records

Labtician Ophthalmics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labtician Ophthalmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labtician Ophthalmics

What does Labtician Ophthalmics do?

Labtician Ophthalmics is a Canadian commercialization partner for international eye care brands and manufacturer/distributor of its own-branded ophthalmic medical devices and therapeutic products. The company imports, distributes, and sells a comprehensive portfolio covering surgical instruments (LabEdge blades, knives, cannulas, trephines), vitreoretinal products (Labtician LSO silicone oil, retinal implants, Fluoron silicone oils), glaucoma devices (KDB Glide, Ahmed valves), dry eye therapies (LabTRIACTIV drops, LabHEAT mask, PRGF autologous eye drops, LabEssentials kit), and oculoplasty products to eye care professionals (ophthalmologists and optometrists) and patients across Canada, with international distribution reach spanning 60+ countries.

Is Labtician Ophthalmics a public or private company?

Labtician Ophthalmics is a private company. It is classified as family owned and is currently operating.

When was Labtician Ophthalmics founded?

Labtician Ophthalmics was founded in 1959. It employs 11 to 50 people.

Where is Labtician Ophthalmics based?

Labtician Ophthalmics is headquartered in Oakville, Canada, in the North America region.

How does Labtician Ophthalmics make money?

Two revenue lines are on record. Distribution and commercialization of ophthalmic medical devices and therapeutic products are the primary driver. The others are endoret PRGF treatment services.

Who are Labtician Ophthalmics's main competitors?

Direct peers on record are Glaukos Corporation, Sight Sciences, BVI (BVI Medical), STAAR Surgical and Iridex Corporation. Broad incumbents are Alcon, Topcon Healthcare, Carl Zeiss Meditec and Bausch + Lomb. NovaBay Pharmaceuticals is listed as an emerging player.

Does Labtician Ophthalmics have an API?

No public API is recorded for Labtician Ophthalmics.

What industry is Labtician Ophthalmics in?

Labtician Ophthalmics's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions), with a secondary code of HLAHAIAL, Ocular Drug Delivery Devices (Eye Droppers/Inserts). Its NAICS code is 423460 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireDIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreementDIAGNOS renewed its distribution agreement with Labtician for the Canadian territory, extending the partnership for three years. The renewed deal enables a diabetic retinopathy screening service in Ontario endocrinology clinics using OHIP remote assessment codes. The initiative aims to improve eye care access for diabetic patients and reduce vision loss risk.GlobeNewswireDIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician OphthalmicsDIAGNOS Inc. announced the kick-off of its Pathology Detection Systems in endocrinology clinics with distribution partner Labtician Ophthalmics, covering over 77,000 patients across Canada. The partnership, signed in February 2021, aims to address growing needs in monitoring diabetic and hypertensive patients. The company expects recurring revenue from clinic onboarding.GlobeNewswireDIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of DiabetiDIAGNOS announced an exclusive strategic partnership with Labtician Ophthalmics to commercialize its CARA AI platform for diabetic eye monitoring in Canada. The agreement, formalized in February 2021, follows an initial deal in June 2020 and aims to access new Canadian customers. The platform is cleared by Health Canada, FDA, CE, and other regulators.GlobeNewswireDIAGNOS Announces Signing of Strategic PartnershipDIAGNOS announced a strategic partnership with Labtician Ophthalmics to access new Canadian customers for its AI-based ocular health monitoring. The agreement aims to expand DIAGNOS's footprint without significant workforce investment, targeting diabetic and hypertensive patients. DIAGNOS plans similar partnerships in aligned medical verticals.openPR.comAphakia Market by Top Key Players: The Cooper Companies Inc., Menicon Co., Ltd., Labtician Ophthalmics, Inc., Artificial Eye Co., Contact Fill, ALLERGAN, MJS Lens Technology Ltd., Alsanza MedizintechnThe global aphakia market is projected to grow at a CAGR of 9.4% from 2018 to 2024, with North America expected to dominate in 2017. The market is segmented by type, cause, treatment, end user, and geography, covering 28 countries.